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Abstract Although the survival rate of cancer patients has significantly in-
creased due to advances in anti-cancer therapeutics, one of the major side
effects of these therapies, particularly radiotherapy, is the potential manifes-
tation of radiation-induced secondary malignancies. In this work, a novel evo-
lutionary stochastic model is introduced that couples short-term formalism
(during radiotherapy) and long-term formalism (post treatment). This frame-
work is used to estimate the risks of second cancer as a function of spontaneous
background and radiation-induced mutation rates of normal and pre-malignant
cells. By fitting the model to available clinical data for spontaneous background
risk together with data of Hodgkin’s lymphoma survivors (for various organs),
the second cancer mutation rate is estimated. The model predicts a significant
increase in mutation rate for some cancer types, which may be a sign of ge-
nomic instability. Finally, it is shown that the model results are in agreement
with the measured results for excess relative risk (ERR) as a function of ex-
posure age, and that the model predicts a negative correlation of ERR with
increase in attained age. This novel approach can be used to analyze several
radiotherapy protocols in current clinical practice, and to forecast the second
cancer risks over time for individual patients.
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1 Introduction
The evolution of radiation medicine coupled with various technological ad-
vances, in therapeutic radiation treatments has dramatically improved the
survival rate of cancer patients over the last several decades. Current treat-
ment techniques deliver doses to the gross tumor volume with great precision.
However this comes at the cost of damaging healthy tissue in the vicinity of the
tumor, leading to the possible manifestation of a secondary tumor post treat-
ment in many cancer survivors, which may occur sometimes several decades
after treatment(Xu et al, 2008). Due to the higher survival rate of cancer
patients in recent years, the investigation of secondary malignancy risks due
to radiation therapy has now become of greater importance than ever. The
fact that the survival rate of patients (for example Hodgkin’s Lymphoma,
Leukemia and Sarcomas) has improved to several more decades suggests that
one needs to construct a model that can predict the age and time-dependent
risks of second cancers. Radiation-induced cancer risks have been well docu-
mented in atomic bomb survivors mortality studies (Preston et al, 2007)(Little,
2009). There is also evidence from epidemiological studies that the mortal-
ity rate of Hodgkin’s Lymphoma survivors is high post radiation treatment
(Aleman et al, 2003)(Bhatia et al, 2003). Several cohort and case control
studies have indicated that there is an increased risk of second malignan-
cies with young Hodgkin’s Lymphoma survivors post irradiation (Bhatia and
Sklar, 2002)(Hodgson et al, 2007b). Recently, several clinical and modeling
studies have described the risk of of second malignancies for various neigh-
boring organs (Sachs and Brenner, 2005)(Xu et al, 2008)(Moteabbed et al,
2014)(Paganetti et al, 2012)(Athar and Paganetti, 2011)(Hall, 2006)(Manem
et al, 2014a). Some of these clinical studies have suggested that there is a high
incidence rate of breast cancer among young Hodgkin’s Lymphoma survivors
compared to women treated in middle age (Travis et al, 2005). Children treated
with radiotherapy are particularly vulnerable to radiation-induced carcinogen-
esis (Bhatia and Sklar, 2002). Several clinical findings indicate that second
cancer risks change with respect to age at exposure and also with respect
to time since exposure (Travis et al, 2005)(Dores et al, 2002). Some authors
studied the efficacy of dose escalation on secondary cancer induction(Manem
et al, 2014b)(Schneider et al, 2007). It has also been noted that the latency
period is typically between 10 to 20 years for solid tumors, and around 5 years
for leukemia post irradiation (Zhang et al, 2012)(Wang et al, 2014)(Schnei-
der et al, 2014)(van Leeuwen et al, 2003)(Yeoh and Mikhaeel, 2010)(Yahalom,
2009)(Hodgson et al, 2007a). As a result of increasing prevalence of secondary
malignancies, it is clearly of great importance to investigate the risks associ-
ated with different treatment regimens as well as their possible variation with
age (by incorporating age at exposure and time since exposure)(Hodgson et al,
2007b). Site-specific dose-response relationships for cancer induction from the
combined Japanese A-bomb and Hodgkin cohorts for doses on a par with ra-
diation bomb survivors, has been actively studied in the literature (Preston
et al, 2007)(Preston et al, 1994). The approaches taken are phenomenologi-
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cal models assuming the temporal pattern of risk to be an exponential power
law (Preston et al, 2007). With respect to the baseline rates, (Preston et al,
2007) showed that these are proportional to the attained age raised to the
power of 5.5, and decrease around the age of 90. Another point to take into
consideration is that gender appears to play a major role in defining the base-
line rates. This type of analysis of cancer incidence among A-bomb survivors
indicates that the cancer risk (excess relative risk) is a function of time and
decreases with age, thus leading to the conclusion that, for long-term age de-
pendent models, both exposure age and attained age are important factors to
incorporate. At the same time however, age-dependent factors are difficult to
model in practice. Radiation-induced second cancers are thought to arise as a
result of multiple mutations of healthy cells (or pre-cancerous, pre-malignant
cells) post irradiation of the primary tumor (Sachs and Brenner, 2005)(Lindsay
et al, 2001)(Schneider, 2009). Pre-malignant cells are those cells that have the
potential to turn into malignant cells. The process is very complex to model
due to variations in various biological mechanisms in patients (that depend on
habits, or environmental exposure). As discussed in the literature on primary
cancer age incidence modeling (Armitage, 1985)(Armitage and Doll, 1954), the
manifestation of a second cancer is considered here to be the result of a two-hit
process. It is assumed that anti-cancer therapies, such as radiation treatment,
introduce a first hit to some of the normal cells in the vicinity of the tumor.
This introduces a sub-population of radiation-induced pre-malignant cells in
the system (see (Sachs and Brenner, 2005) and references therein). The de-
tailed bio-physical mechanisms of pre-malignant cells resulting from radiation
exposure, are still not well understood. Additionally, radiation therapy has a
destructive effect on the tissue architecture, leading to some changes in the
spatial structure of the tissue (see for example (Yorke et al, 1993)). It has also
been suggested that radiation therapy can introduce chromosomal instabili-
ties, and thus make the second hit mutations more effective and unpredictable
in nature (Huang et al, 2003). In the presence of genomic instability, the possi-
bility of having a hit on a particular locus is broadened into a range of hits and
changes across a pair of chromosomes. However, there is no direct evidence for
genomic instability as a result of radiation exposure, and there are several on-
going debates on some intriguing questions related to the conditions required
for genomic instability (Bhatia and Sklar, 2002)(Sigurdson and Jones, 2003).
On the other hand, the progression of cancer and evolutionary dynamics of
two-stage models of cancer progression have been discussed in the existing
literature. The latter were developed to quantify the dynamics of how an ad-
vantageous mutant (pre-malignant cell) can outgrow a background population
of normal stem cells and upon a second (malignant) mutation resulting in a
malignant niche and eventually resulting to a secondary malignancy. These
models have also been successfully applied to describe dynamics of chromoso-
mal instability by different authors (Komarova et al, 2003)(Nowak et al, 2002).
It has also been proposed that second cancers may arise due to the creation
of residual pre-malignant cells (cells due to radiation treatment) which can
proliferate in between therapies and eventually grow afterwards (Sachs and
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Brenner, 2005). In this paper, a mathematical model is construced to predict
the excess relative risk (ERR) of second cancers due to radiation exposure
during treatment of a primary malignancy. The presented framework captures
the stochastic nature of such complex evolutionary systems. The parameters of
the model are: (i) the mutation rate after radiation exposure which is assumed
to be different from the background value of the mutation rate and, (ii) the
proliferation strength of the pre-malignant cells. The dependence of the ERR
on attained age and age at exposure of the patients is predicted by the model.
2 Materials and Methods
In this section the mathematical model used to estimate the ERR due to ra-
diation exposure is briefly discussed. The mathematical details of the model
are presented in Appendix A. The framework used is built on the evolutionary
model of cancer initiation/progression of two-hit mutation models of tumor
suppressor gene inactivation (TSG), and the evolutionary dynamics of chro-
mosomal instability developed by Nowak et al. (Komarova et al, 2003)(Nowak
et al, 2002).
In modelling the risks of secondary malignancies post irradiation, a new
time scale (age at exposure te) is introduced to capture the effect of radiation-
induced pre-malignant cell initiation. It is assumed that radiation-induced sec-
ondary cancers are initiated by mutated stem cells. In a two-hit mechanism, it
is further assumed that normal stem cells can be mutated into pre-malignant
cells (also known as type-1, or one-hit cells). This random event occurs ei-
ther by spontaneous mutation, or, as a result of a radiation-induced initiation
mechanism during treatment. Each pre-malignant cell can then undergo a sec-
ond spontaneous mutation and transform into a malignant phenotype (also
known as a type-2, or two-hit cell). Malignant cells can eventually initiate tu-
mor clones. The two hit hypothesis here is a reflection of the fact that one is
focusing on the malignancies induced by tumor suppressor gene inactivation
(TSG). In the case of TSG inactivation, a single mutation does not lead to
loss-of-function for a cell, due to which it is assumed that pre-malignant cells
have a very weak selection advantage/disadvantage over normal stem cells;
while malignant cells are expected to have a significantly higher proliferation
potential.
The premise is that stem cells populate stem cell niche areas in the tissue
which are homeostatically regulated. The proliferation/selection of the three
types of stem cells- normal, pre-malignant, malignant- determine the pheno-
type that will eventually take over the corresponding niche. It is assumed that
the selection mechanism is governed by a stochastic birth-death model, (i.e.
Moran process (Moran, 1962)(Durrett, 2008)). The form of the growth term of
advantaged phenotypes (normally type-2 and also marginally type-1 cells) is
reminiscent of logistic growth with the carrying capacity being the niche size.
It is assumed that the total number of stem cells (either normal, pre-malignant,
or malignant phenotypes) is a constant, N (within each niche). This number
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can vary between 10− 106 (depending on the organ type). The total number
of the niches is denoted by N˜ , which is generally a large number (∼ 107). The
first and second spontaneous (background) mutation rates are denoted by u1
and u2. The second mutation rate for the irradiated (normal) tissues is distin-
guished by ur (rather than u2) to indicate the secondary effects of radiation on
pre-malignant cells. One of the probable secondary effects of ionizing radiation
may be radiation-induced genomic instability which has been suggested in the
literature ((Sigurdson and Jones, 2003), (Komarova et al, 2003), (Nowak et al,
2002)). Moreover, the number of malignant stem cells created by radiation is
ignored due to their small number relative to the pre-malignant cells.
The effects of ionizing radiation in the proposed framework can be sum-
marized as follows:
– Radiation transforms normal cells into pre-malignant cells. These addi-
tional pre-malignant cells are distributed among the niches. As stated pre-
viously, the contribution of direct two-hit transformations due to radiation
is ignored as the event is assumed to be a rare process.
– There is an effective second hit mutation rate, ur for all the pre-malignant
cells that is different from u2. The approximate value of ur can be estimated
from the clinical data for cancer risk estimates.
– Due to the small numbers of pre-malignant cells relative to the total number
of niche areas, only a small subgroup of niches will contain pre-malignant
cells after treatment.
Figure 1 depicts a caricature of a two-hit process for background cancer and
radiation-induced cancer. The dynamics of transformation from normal to pre-
malignant tissue is displayed in figure 2.
In the absence of radiation, the probability of having at least one malignant
cell (resulting through the sequential mutations u1, u2) is calculated in a niche
before time t, i.e. attained age, denoted by f0(t, u1, u2, r,N). For large niche
sizes (typically N ≥ 10), a branching process approach is deemed appropriate
for the two-hit model. An explicit form for f0(t, u1, u2, r,N) can be obtained
(see Appendix A and (Iwasa et al, 2005)),
f0(t, u1, u2, r,N) = 1− exp
[
−Nu1 ·
(
a+ b
c
· ln
{
ect + a/b
1 + a/b
}
− bt
)]
, (1)
Where coefficients a, b and c are functions of the second mutation rate (u2) and
proliferation/repopulation rate (r) given in Appendix A. Upon the appearance
of a malignant stem cell in a niche, due to its high fitness advantage, there is
a high probability for it to take over the whole niche and form a malignant
niche. The overall probability of a malignant clone arising at time t is given by:
ρ(r˜, N)f0(t, u1, u2, r,N), where ρ(r˜, N) is the fixation probability of malignant
cells with a proliferation strength r˜ (the fixation probability is the probability
that one malignant cell takes over the whole niche). We assume a much higher
proliferation rate for malignant cells than for pre-malignant or normal cells
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Fig. 1 Two-hit model of background and radiation-induced second cancer a) In the back-
ground two-hits on the wild type allele A, occur randomly with rates u1 and u2. b) For the
case of second cancer the first mutation happens during the radiation treatment for a small
population of normal stem cells (with rate γ), because of the possible after effects such as
genetic instability induced by radiation the second cancer mutation rate, ur, is assumed to
be different from the background rate, u2.
and thus the average time to fixation is much shorter relative to the time
scales of the latency time of secondary cancer, and given by
tlag = ∆tfixation ∼ 1
r − 1 lnN 
1
u2
. (2)
The left-hand-side of equation (2) is the approximate value of the fixa-
tion time (Durrett, 2008). The the fixation time for a malignant phenotype is
treated as a free parameter that indicates the lag time from the appearance
of the first malignant stem cell in a niche until it fixates the system.
As a result of radiation exposure, extra numbers of pre-malignant cells
are initiated during radiation treatment. This number is on the order of one
pre-malignant cell per million normal cells (if distributed uniformly in all the
niches) (Sachs and Brenner, 2005). Hence, it is assumed that the radiation-
induced as well as the spontaneously created pre-malignant cells are evenly
distributed among a subpopulation of niches, i.e. there is a small number of
stem cells niches which each have one type-1 cell and N − 1 type-0 cells, soon
after radiotherapy, while the majority of niches are filled with type-0 cells. The
dynamics of these two initial conditions are inherently different. The probabil-
ity of having at least one malignant, type-2, cell arise at time t after radiation
exposure (in a niche or compartment), is denoted by f1(t, u1, ur, r,N). Notice
that the value of the second mutation rate is now changed to ur. Under a sim-
ilar branching process approximation, the functional form of f1(t, u1, ur, r,N)
is taken to be:
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u1 ⇢1
N
u2
⇢2
a)
N
⇢1
⇢2
b)
ur
Fig. 2 Normal and pre-malignant cell kinetics until transformation to a malignant niche.
a) Background scenario, successive events are a first hit mutation (rate u1) which creates a
pre-malignant cell which outgrows normal cells with probability ρ1. Consequently, a second
hit (rate u2) creates a fully malignant phenotype which can outgrow premalignant stem cells
with fixation probability ρ2. b) Post-radiation scenario: A small number of pre-malignant
cells are initiated due to radiation and are distributed among normal stem cell niches, they
outgrow in time and can transform into malignant cells with a different mutation rate ur,
(yellow: pre-malignant red: malignant).
f1(t, u1, u2.r,N) =
e{r(1−u2)(a+b)t} − 1
(1/a)e{r(1−u2)(a+b)t} + (1/b)
, (3)
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Similarly, the probability of having a malignant niche after time t is
ρ(r˜, N)f1(t, u1, u2, r,N). To estimate the risk of cancer initiation, it is as-
sumed that the probability of cancer initiation is proportional to the number
of malignant niches. It is also assumed that in both background and radiation-
exposed cases the number of malignant cells created before the exposure-age
is negligible, but there can be a number of pre-malignant cells that underwent
spontaneous initiation, and these are denoted by M0, while the number of
radiation induced pre-malignant cells after radiation is denoted by M1. Thus,
after radiation exposure, there are M0 + M1 niches with one pre-malignant
cell distributed per niche; and N˜ −M0 −M1 niches with zero pre-malignant
cells. Similarly in the background case the same scenario is assumed, but with
only M0 niches containing a pre-malignant cell. This can be summarized as
follows:
number of malignant
cells (background)
= N ρ˜ {M0 f1(t, u1, u2, r,N)
+ (N˜ −M0) f0(t, u1, u2, r,N)}.
number of malignant
cells (irradiated)
= N ρ˜ {(M0 +M1) f1(t, u1, ur, r,N)
+ (N˜ −M0 −M1) f0(t, u1, ur, r,N)}, (4)
where ρ˜ = ρ(r˜, N) and t = ta− te− tlag is the time since exposure, while ta, te
and tlag are attained age, age at exposure and lag time as discussed in previous
section. The ratio of the above two equations gives a good approximation to
the ERR for second cancers. Using the definition of Relative Risk (RR) and
Excessive Relative Risk (ERR),
RR = 1 + ERR =
(
number of malignant
cells (irradiated)
)/(
number of malignant
cells (background)
)
, (5)
now, the number of initiated pre-malignant cells during the irradiation time
M1, can be estimated using the initiation-inactivation-proliferation model pro-
posed by Sachs and Brenner (Sachs and Brenner, 2005)
(see also (Sachs et al, 2007)) for a given radiotherapy protocol. Ntot(= NN˜)
denotes the total number of normal cells, γ (Gy−1) denotes the initiation rate
of normal cells to pre-malignant cells, then a constant dose delivery rate (ra-
diation strength) leads to a simple form for M1 given by:
M1 ≈ Ntot(eγD − 1), (6)
It is again assumed that the number of malignant cells prior to radiation treat-
ment is negligible so that, the number of pre-malignant cells M0 that result
from spontaneous mutations before the radiation exposure time, M0, can be
approximated from a simple evolutionary Moran model with two populations
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of normal and pre-malignant cells. This leads to the forms for M1 (as in (Sachs
and Brenner, 2005)), and
M0 ≈ N(1− e−ρNu1te), (7)
where te is the age at exposure. Notice that similar forms are used for the in-
cidence rates in the presence and absence of radiation. The effects of radiation
only appear in the altered value of the second mutation rate with an addi-
tional number of pre-malignant cells. The fact that the same form equation
(4) can be used for the background incidence rate relies on the assumption
that the number of malignant cells developed before the radiation exposure
time, is negligible. This will lead to a number of new incidences after the radi-
ation exposure age. Therefore, these approximations limit the ERR estimates
to decades after the radiation exposure. However, this is a well known fact
from epidemiological studies of second cancers (Preston et al, 2007).
Figure 3 displays sensitivity of the probability that one malignant cell arises
before time t in a system filled with normal cells. To show the general behaviour
of the function f0(t, u1, u2, N, r) for various parameter values, both changes in
mutation rate u1 and/or proliferation rate r lead to a similar behaviour to that
of slowing down the background probability f0(t, u1, u2, N, r) as a function of
time.
3 Results
3.1 Background Age-Incidences
Using the model described above, (i) the time-dependence of the excess rela-
tive risks of radiation for second cancer, and (ii) the effective mutation rate
of pre-malignant cells resulting from radiation therapy were calculated. The
model was fitted with the background incidences for colon, breast and lung
cancers using data extracted from (Shuryak et al, 2009a)(Shuryak et al, 2009b).
The value of the proliferation rate, r, can be obtained from these fits. In this
framework, the niche size has a very weak impact on the value of ERR. It is
assumed that N ∼ 10 for the case of colorectal cancer as the stem cell niches
are restricted to the bottom of each crypt with small populations. For other
organs, a much larger value N ∼ 10000 is used. For the mutation rate values,
an estimate from (Iwasa et al, 2005) is employed that approximates the mu-
tation rates for tumor suppressor gene inactivation. A gene is approximately
10kb long, and we assume a hit on 5 per cent of bases (500 bases) can cause
a change-of-function mutation, while each hit might occur with a probability
of 10−10 per cell division (Michor et al, 2004)(Kunkel, 2004). This gives the
effective rate of mutation on each gene u1 ∼ 10−7 while each generation is as-
sumed to last about a week. Since the gene can affect either of the two alleles,
for the second mutation rate, u2, the probability of mutation is higher due to
mechanisms of loss of heterozygosity (mitotic recombination and chromosome
non-disjunction). Thus, u2 is assumed to be on the order of 10
−6. For the
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Fig. 3 Probability that a single malignant cell arises (before time t) in the system filled with
normal cells for various parameter values. a) fixed mutation rates and variable proliferation
rates r. b) Fixed proliferation rate r and variable mutation rates (u2 = 10u1).
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Fig. 4 Model fitting with the background incidence data for colon, lung and breast can-
cers from SEER database (http://seer.cancer.gov/data/). Different graphs correspond to
different values of proliferation rate r0.
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above estimates a range of first mutation rates varying between 10−8 − 10−6
is considered, while assuming u2 to be an order of magnitude larger than u1.
Using a lag time of 20 years, results for different cancer incidence models are
fitted. This does match the values reported in the literature and is also of
the the same order of magnitude as that given by equation (2), which is the
theoretical measure of the lag time.
The results from Surveillance, Epidemiology and End Results (SEER)
database (http://seer.cancer.gov/data/) is plotted in Figure 4 for different
values of proliferation rates. For the figure, r = 1.05 − 1.1, N = 10 for colon
cancer; r = 1.03 − 1.05, N = 104 for breast cancer and r = 1.07 − 1.1 with
N = 104 for lung cancer was chosen.
These values give a crude estimate of the second mutation rate post irradi-
ation. In the following section, an estimate of ur taken from the atomic bomb
survivors data is given. Figure 4 displays the model fit with the background
incidence data for colon, lung, breast cancers using the above estimated values.
3.2 Dose-Response in Atomic Bomb Survivors- ur Estimate
The dose response relation for atomic bomb survivors has been reported in the
literature (see (Preston et al, 2007)). The average dose received by survivors
is about 0-3 Gy (Preston et al, 2007) (with average estimated to be 0.5Gy).
The dose-response has a linear functional form for the low dose regions, and
gradually bends for high doses (Figure 5 displays a plot for low dose region - for
all solid cancer incidences). The slope of the linear-fit (which passes through
the origin and is indicated by the blue line) is 0.46 per Gy, denotes the weighted
absorbed dose, and encompasses the dose from neutrons (which is multiplied
by an RBE value of 10 to make it equivalent to the gamma dose).
The dose-response relation reported uses the standardized ERR which is for
age at exposure of 30 years and an attained age of 70 years. The dose-response
graph can be fitted with a linear function for which the slope indicates the
value of ERR per dose. Inserting the value for slope into the analytical form for
the ERR, equation (4) and using the rough estimates for background mutation
rates and proliferation strengths (u1 = 10
−7, u2 = 10−6, r = 1.05 as discussed
above), we solve for the value of the radiation-induced mutation rate,
ur ' 1.0× 10−3(Gy−1 generation−1). (8)
Since the dose response plot is a cumulative risk for all solid cancers, the
above estimate is a good order of magnitude approximation. A much higher
value of the mutation rate relative to the background value of u2 ∼ 10−6 is
noticeable. This is interpreted as due to the fact that the secondary effects of
radiation probably results in the induction of genomic instability in the model,
which effectively manifests itself in the value of the second hit probability.
Tables 1, 2 shows the range of values of the second mutation rates as u1 is
varied between 10−8 to 10−6 (while keeping u2 ∼ 10u1 and r varies between
1.001-1.05.
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Fig. 5 ERR vs. Dose for total solid cancer incidences, age at exposure of 30 years and
attained age of 70 years (Data points extracted from (Preston et al, 2007)). The slope of
the linear fit is used to estimate the mutation rates in a two-stage model of cancer initiation
for atomic bomb survivors, (see equation (8)).
3.3 ERR vs. Exposure Age, Hodgkin’s Lymphoma Survivors
In order to obtain similar results for second cancers as a result of radiation ther-
apies, the model is applied to the SEER data on second malignancies among
Hodgkin’s lymphoma survivors. The estimates for the background mutation
rates and the proliferation strength are further tested by fitting the ERR as a
function of exposure age (attained age is fixed at 70 years). Here, the results
for three types of cancers, namely, colon, breast and lung, are reported. Using
averaged values of ERR over age of exposure for each cancer type, we solve for
the values of ur, and use it in equation (5) to plot ERR as a function of age
at exposure (te). Fits were done for values of u1 in the range ∼ 10−8 − 10−6,
and for small proliferation strengths r ∼ 1.01− 1.1. The values of the best fits
are reported in Table 2 and the dependence of exposure age on the ERR is
displayed in Figure 6.
As can be seen, risk is an increasing function of the exposure age as it
approaches the attained age of 70. This is in fact in agreement with the phe-
nomenological studies of Preston et al. (Preston et al, 2007) in which a Poisson
regression analysis is used by assuming a log-quadratic form in their assump-
tion for ERR exposure age dependence.
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Fig. 6 ERR vs. exposure age for colon, breast and lungs among Hodgkins Lymphoma
survivors from SEER data (http://seer.cancer.gov/data/ see also (Shuryak et al, 2009b))
. Solid lines are the best fit from the presented model using background parameter values
from SEER background incidence rates.
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Table 1 Best fit mutation rates for background incidence curves, along with the post radi-
ation induced mutation rate.
Table 2 Second cancer mutation rate estimates for colon, breast and lungs
3.4 ERR vs. Attained Age- Hodgkin’s Lymphoma Survivors
The above analysis will allow prediction of the risks of second cancer for dif-
ferent age groups and for different attained ages. The predicted ERR’s are
reported in Figure 7. Notice that the different age groups of 10 years, 30 years
and 50 years display different behaviors of the ERR. This is due to the fact
that different values of ERR are used as the input to estimate ur for each age
group in addition to differences in the age at exposure that explicitly appears
in equation (5). In other words, the effect of age at exposure on the second can-
cer risk at a given age (attained age) is two fold: 1) ERR explicitly depends on
the age at exposure in equation (5). 2) The value of the second mutation rate,
ur depends on the age at exposure and thus should be determined separately
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for each age group. This is done by using the results of ERR vs age at exposure
discussed in the previous section. While the mutation rate, ur, was estimated
for standardized attained age of 70 years old in the previous section, exposure
ages of 10, 30 and 50 years old are used from Figure 6 for ERR to estimate
a new mutation rate value for each exposure age group. Unsurprisingly, this
secondary effect is not very significant as the ERR values do not change much
for different exposure ages (with the exception of lung cancer). The above re-
sults can be compared with the phenomenological findings of Preston (Preston
et al, 2007) and Shuryak et al (Shuryak et al, 2009a), (Shuryak et al, 2009b).
The importance of the present result is that one can confirm the behavior
of the ERR on a more general grounds based on two-stage mutation model,
while much of the details of the model such number of stem cell niches, N˜ ,
and niche size, N , proliferation rate, r and mutation rates u1,2 and ur denote
the mutation rates.
It is worth mentioning that for organs with strong hormonal production
such as thyroid and breast, one does expect a deviation of the predicted ERR
around certain ages where hormone production can aggravate the risk. This
can be seen as a slight deviation in Figure 6 (for breast) around an exposure
age of 15-20. The reader is referred to (Shuryak et al, 2009b) for a similar
deviation in thyroid secondary primary cancers from Hodgkin’s Lymphoma
survivors. Similar deviations can be observed in the fits for SEER breast can-
cer incidences in Figure 4 after age 60, which we propose might be influenced
by a similar hormonal mechanism. However, it is suggested that the over all
framework especially the estimate of second cancer mutation rate and possi-
bility of genomic instability due to radiation is independent of such details.
Further investigation of hormonal effects and its interplay with other mecha-
nisms of radiation induced cancers remains a subject for further investigation.
4 Discussion
In the present paper a biologically motivated evolutionary model is described
to forecast radiation-induced second cancer risks over time, post irradiation.
The mathematical framework adopts an evolutionary dynamics approach, par-
ticularly with respect to the two-hit mechanism used to model cancer initi-
ation. This two-hit process accounts for two types of mutations that occur
in normal cells, similar to that of tumor suppressor gene inactivation. The
assumption is that normal cells can mutate to pre-malignant cells during ra-
diation treatment, which in turn transform to malignant cells over a period
of time. The second mutation can be correlated to either genomic instabil-
ity (which is considered to be one of the secondary effects of radiation), or,
to spontaneous mutation (due to the effects of several carcinogens from, for
example, food, background radiation, etc).
The current unified framework is an improvement over other models found
in the literature. The short-term model allows one to consider various radi-
ation therapy protocols used in current clinical practice. The output of this
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Fig. 7 Predicted values for ERR vs. Attained age for various age groups for colon, breast
and lung cancers. The parameters in equation (5) are fixed using SEER background data
(http://seer.cancer.gov/data/). Different segments of each graph correspond to exposure
ages of 10, 30 and 50 years old. A similar distinction is done in (Preston et al, 2007)(see
discussion in the text).
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biological model is then used as an input to track the number of malignant
niches over time to predict the changes in ERR over time, using a simplified
evolutionary model. One of the major improvements over existing models is
that a stochastic formalism is used to predict ERR over time. This seems a
more realistic approach for applications to clinical data since mutations appear
to occur randomly post irradiation. Another major advantage of the presented
model is that it has fewer parameters compared to other existing models.
This framework takes into consideration the short-term biological mecha-
nism of pre-malignant cell initiation, along with a long-term formalism re-
sulting in the manifestation of a secondary tumor. The short-term model
adopts the initiation-inactivation-proliferation model of Sachs and Brenner
(Sachs and Brenner, 2005) to estimate the number of radiation-induced pre-
malignant cells at the end of treatment. The long-term formalism relies on an
evolutionary model of the two-hit processes similar to the tumor suppressor
gene inactivation model. An evolutionary model is developed based on the un-
derlying biological assumptions. The two important parameters in the model
are proliferation strengths and mutation rates which are estimated from the
atomic bomb survivors data. The results from the presented model are consis-
tent with those of the work of Preston et al (Preston et al, 2007).
In the present paper, the model was applied to patient survivors of Hodgkin’s
Lymphoma. For this, the proliferation strengths and mutation rate parameters
were extracted for various organs (in particular: colon, breast and lungs) from
the background incidences (taken from the SEER database). This was done by
fitting the developed analytical functions to the background incidence curves,
in order to obtain mutation rates and proliferation strengths. Then these values
were used to predict ERR’s for various attained and exposure ages. The pre-
dicted age- dependent ERR values are consistent with epidemiological findings
and clinical studies. An important point to highlight from the present calcu-
lations is that the mutation rate post irradiation (ur), is greater than that of
the second mutation rate (u2) for background incidence. It is also observed
that for low proliferation rates and for low risk, the corresponding ur estimate
is similar to u2.
In future work, we intend to extend our framework to include therapeu-
tic doses using dose-volume histograms (DVH) and validate this on existing
second cancer data sets. It is also intended to extend this work to compare
more contemporary protocols for various radiotherapy treatment techniques to
predict the risk of second cancers for individual patients. There are several on-
going debates on the effects of radiation, (e.g concerning genomic instability).
It is planned to modify the model to investigate and understand the effects of
radiation on tissue architecture as well as on genomic instability.
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A Evolutionary Dynamics of Two-Hit Process
Consider a population of N cells (inside a niche) governed by the Moran pro-
cess (type-0,1,2 indicating normal, pre-malignant and malignant phenotypes).
At each time step a cell is randomly chosen, based on its fitness, to reproduce
and another cell is randomly chosen to die. In the presence of mutations, such
as in the model presented in this paper, at each time step there is an alter-
native possibility (instead of death-birth) that a normal cell may transform
into a pre-malignant cell or alternatively a pre-malignant cell may transform
into a malignant cell. The mutation rate for the first hit is u1 and the rate for
the second hit (pre-malignant into malignant) is u2 (or ur after radiation). As
discussed in the text, let f0(t, u1, u2, r,N) be the probability that a first malig-
nant cell has emerged before time t given that the initial population consists of
all normal cells in the niche. Similarly, let f1(t, u1, u2, r,N) be the probability
that a malignant cell emerges in a niche of size N before time t, beginning with
one pre-malignant cell and N − 1 normal cells. It is straightforward to show
that the two probabilities satisfy the continuous time limit of the Kolmogorov
equations,
df0(t)
dt
= Nu1f1(t) (1− f0(t)) ,
df1(t)
dt
= ru2 − (1− r + 2ru2)f1(t)− r(1− u2)f21 (t), (A.1)
with the initial condition f0(0) = 0. The solutions of the above set of equa-
tions can be directly obtained under a branching process approximation, i.e.
independence of two lineages starting from two different cells, one can then
obtain an analytical solution for these probabilities,
f1(t, u1, u2, r,N) =
exp
{
(r(1− u2)(a+ b)t
}
− 1
(1/a) exp
{
r(1− u2)(a+ b)t
}
+ (1/b)
,
f0(t, u1, u2, r,N) = 1− exp
(
−Nu1
{
a+ b
c
ln
[
ect + a/b
1 + a/b
]
− bt
})
, (A.2)
with a, b, c given as,
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a =
1
2(1− u2)
−(1− r
r
+ 2u2
)
+
√(
1− r
r
+ 2u2
)2
+ 4u2
 ,
b =
1
2(1− u2)
(1− r
r
+ 2u2
)
+
√(
1− r
r
+ 2u2
)2
+ 4u2
 ,
c = r(1− u2)(a+ b). (A.3)
As discussed in the main body of the paper, both the cumulative age-
incidence of different cancer types and excess relative risk of cancer (second
cancer in this case) is expressed in terms of functions f0(t, u1, u2, r,N) and
f1(t, u1, u2, r,N), which lead to a simple form for the ERR. As is obvious
there is no dependence on the total number of niches N˜ , and the dependence
on the niche size, N , is very weak. However, for more realistic fits the value
of the proliferation strength r is not extremely close to unity and thus the
above approximation might not be appropriate. However, it is easy to see
from the above approximate results that any quantity of interest (i.e. number
of background age-incidences or ERR) is represented by very weak functions
of the niche size, N . Thus the present rough estimates for the value of N do
not change any of the important conclusions resulting from this work.
B Initiation-Inactivation-Repopulation Model
In this section the initiation-inactivation-repopulation
(Sachs and Brenner, 2005) formalism is briefly reviewed to estimate the num-
ber of pre-malignant cells at the end of radiation treatment. The effect of
radiation is simplified into two mechanism: 1) cell killing which is modelled by
the linear-quadratic approximation and gives the number of either normal or
pre-malignant cells killed due to radiation dose. 2) The cell initiation which is
assumed to be a linear function of the dose with a small constant mutation rate
per dose rate. Two populations of normal stem cells and pre-malignant stem
cells are assumed. Normal stem cells grow logistically while they can die dur-
ing the radiation exposure times, where cell death is given by linear-quadratic
formula. They can also transform into pre-malignant cells during the exposure
time. The population of pre-malignant cells has a similar growth form while its
proliferation is regulated by the population of normal cells and has the same
cell death rate due to radiation and also a positive rate due to normal stem
cell initiation. The above can be written in the form of the following coupled
system of ordinary differential equations.
dn(t)
dt
= r0n(t)
(
1− n(t)
K
)
− (α+ βD) · dD
dt
n(t)− γ dD
dt
n(t),
dm(t)
dt
= r0λm(t)
(
1− n(t)
K
)
− (α+ βD) · dD
dt
m(t) + γ
dD
dt
n(t), (B.1)
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where r0 is the normal cell repopulation rate while r0λ is the pre-malignant
repopulation rate. dD/dt is the dose delivery rate, λ represents the relative pro-
liferation rate of pre-malignant cells to the normal cells and K is the carrying
capacity of normal cells. α and β are the cell killing rates from linear-quadratic
dose dependence (LQ). The number of pre-malignant cells after the total ra-
diation dose has been applied, is the quantity of importance here. This can be
analytically calculated for the simplified case of an acute dose, dD/dt = const.
applied in a finite interval of time
M = m(∞) = N(exp(γD)− 1),
∼ NγD, (B.2)
where D is the total dose. The total number of the cells Ntot, is given by the
number of niche times the niches size, NN˜ . For the values of the radiation-
induced initiation rate γ, this will result in M/Ntot ∼ 10−6 (per Gy). Since we
are interested on an estimate for number of radiation induced pre-malignant
cells, the details of cell killing mechanism in LQ formula does not appear in
equation (B.2).
The above formalism can be expanded to incorporate fractionation therapy,
i.e., non-constant dose-delivery rate which has been discussed in the literature.
In the present work there is no need to deal with these details. However, as
a future direction of research all the details of radiotherapy (fractionation
protocol and the dose-volume histogram for each patient) can be used as input
to estimate the ERR as a function of exposure age and attained age.
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